|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Human melanoma cells transplanted into zebrafish proliferate,migrate,produce melanin,form masses and stimulate angiogenesis in zebrafish显示文摘 | Haldi M Ton C Seng W L | 2006 | Angiogenesis2006，9，3： | 1 |
| 2 | Human melanoma cellstransplanted into zebrafish proliferate, migrate, produce melanin,form masses and stimulate angiogenesis in zebrafish显示文摘 | Haldi M Ton C Seng WL | 2006 | Angiogenesis2006，9，3： | 1 |
| 3 | Equol is a novel antiandrogen that inhibits prostate growth and hormone feedback显示文摘 | Lund T D Munson D J Haldy M E | 2004 | Biol Reprod2004，70，4： | 1 |
| 4 | Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish显示文摘 | HALDI M TON C SENG W L | 2006 | Angiogenesis2006，9，3： | 1 |
| 5 | Human melanoma cells transplanted into zebrafish proliferate,migrate,produce melanin,formmasses and stimulate angiogenesis in zebrafish显示文摘 | HALDI M TON C SENG W L | 2006 | Angiogenesis2006，9，3： | 1 |
| 6 | Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback显示文摘 | LUND T D MUNSON D J HALDY M E | 2004 | BiolReprod2004，70，： | 1 |
| 7 | Equol is a novel antiandrogen that inhibits prostate growth and hormone feedback显示文摘 | Lund T D Munson D J Haldy M E | 2004 | Biol Reprod2004，70，4： | 1 |
| 8 | Equol is a novel anti-androgen that inhibits prostategrowth and hormone feedback显示文摘 | LUND T D MUNSON D J HALDY M E | 2004 | Biology of Repro-duction2004，70，4： | 1 |
| 9 | Human melanoma cellstransplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish显示文摘 | Haldi M Ton C Seng WL | 2006 | Angiogenesis2006，9，3： | 1 |
| 10 | Androgen inhibits, while oestrogen enhances, restraint-induced activation of neuropeptide neurones in the paraventricular nucleus of the hypothalamus显示文摘 | Lund T D Munson D J Haldy M E | 2004 | J Neuroendocrinol2004，16，3： | 1 |
| 11 | Human melanoma cells transplanted into zebrafish proliferate,migrate,produce melanin,form masses and stimulate angiogenesis in zebrafish显示文摘 | TON C SENG W L | 2006 | Angiogenesis2006，9，： | 1 |
| 12 | Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback 显示文摘 | LUNDTD MUNSON D J HALDY M E | 2004 | Biol Reprod2004，70，4： | 1 |
| 13 | Binocularity following sur-gical correction of strabismus in adults显示文摘 | Mets M B Beauchamp C Haldi B A | 2004 | J AAPOS2004，8，： | 1 |
| 14 | Equol is a novel antiandrogen that inhibits prostate growth and hormone feedback显示文摘 | LUND T D MUNSON D J HALDY M E | 2004 | Biol Reprod2004，70，4： | 1 |
| 15 | Day-to-day blood pressure variability predicts poor outcomes following percutaneous coronary intervention:A retrospective study显示文摘BACKGROUND For patients with cardiovascular disease,blood pressure variability(BPV),distinct from hypertension,is an important determinant of adverse cardiac events.Whether pre-operative BPV adversely affects outcomes after percutaneous coronary intervention(PCI)is to this point unclear.AIM To investigate the relationship between blood pressure variability and outcomes for patients post-PCI.METHODS Patients undergoing PCI in a single state in 2017 were studied(n=647).Systolic and diastolic BPV,defined as both the largest change and standard deviation for the 3-60 mo prior to PCI was calculated and patients with more than ten blood pressure measurements in that time were included for analysis(n=471).Adverse outcomes were identified up to a year following the procedure,including major adverse cardiac events(MACE),myocardial infarction,cerebrovascular accident,death,and all-cause hospitalization.RESULTS Visit-to-visit systolic BPV,as measured by both standard deviation and largest change,was higher in patients who had myocardial infarction,were readmitted,or died within one year following PCI.Systolic BPV,as measured by largest change or standard deviation,was higher in patients who had MACE,or readmissions(P<0.05).Diastolic BPV,as measured by largest change,was higher in patients with MACE and readmissions(P<0.05).CONCLUSION As BPV is easily measured and captured in the electronic medical record,these findings describe a novel method of identifying at-risk patients who undergo PCI.Aggressive risk modification for patients with elevated BPV and known coronary artery disease is indicated. | Cody L Weisel Cornelius M Dyke Marilyn G Klug Thomas A Haldis Marc D Basson | 2022 | World Journal of Cardiology2022，14，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员